Although these findings suggest that ANGPTL4 has an intrinsic role in inhibiting LAL to regulate lipid metabolism and suppress ccRCC tumor growth, there are still questions remaining, and several key directions and strategies can be considered. The gene discussed is ANGPTL4; the disease is nonpapillary renal cell carcinoma.